fluphenazine depot has been researched along with haloperidol in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 30 (52.63) | 18.7374 |
1990's | 12 (21.05) | 18.2507 |
2000's | 11 (19.30) | 29.6817 |
2010's | 4 (7.02) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Haffmans, PJ; Hoencamp, E; Jansen, GS | 1 |
Sachdev, P; Tang, WM | 1 |
Aravagiri, M; Chabert, N; Marder, SR; Van Putten, T; Wirshing, WC | 1 |
Kalugina, LI; Kopeĭko, GI; Kravchenko, NE; Mirzoian, MG; Ushakov, IuV | 1 |
Cooper, TB; Levinson, DF; Lo, ES; Simpson, GM; Stephanos, MJ; Yadalam, KG | 1 |
McCreadie, RG; Whitehead, A; Wiles, DH | 1 |
Gloersen, BA; Inderbitzin, LB; Lewine, RR; McDonald, SC; Rosen, PB; Vidanagama, BP | 1 |
Amrung, S; Davis, CM; Fidone, GS; Hernandez, JM; Jann, MW | 1 |
Annable, L; Campbell, W; Chouinard, G | 1 |
Achkova, P | 1 |
Beal, MF; Carr, DB; Fisher, J; Martin, JB | 1 |
Simpson, GM; Yadalam, K | 1 |
Domino, EF | 1 |
Lazarus, A | 1 |
Jauregui, J; Kelley, AE; Nadaud, D; Stinus, L | 1 |
Marder, SR; Van Putten, T | 1 |
James, WA; Pary, R; Tobias, CR; Turns, DM | 1 |
Dinan, TG | 1 |
Bellodi, L; Brambilla, F; Brancato, V; Facchinetti, F; Genazzani, AR; Petraglia, F; Smeraldi, E | 1 |
Ellison, GD; Levin, ED; See, RE | 1 |
McCreadie, RG; McKane, JP; Robinson, AD; Stirling, GS; Wiles, DH | 1 |
Wistedt, B | 1 |
Cookson, JC; Gribbon, D; Kennedy, NM | 1 |
Holt, RJ; Zengotita, HE | 1 |
Kissling, W; Krueger, R; Möller, HJ; Trenk, D; Walter, K; Wittmann, B | 1 |
Bonomo, V; Parisi, R; Rapisarda, V | 1 |
Blake, IM; Braddock, LE | 1 |
Bourne, RC; Cross, AJ; Gamble, SJ; Waddington, JL | 1 |
Davis, CM; Ereshefsky, L; Jann, MW; Richards, A; Saklad, SR; Seidel, DR | 1 |
Beal, MF; Martin, JB | 1 |
Asarnow, RF; Marder, SR; Van Putten, T | 1 |
Bacopoulos, NG; Bustos, G; Redmond, DE; Roth, RH | 1 |
Annable, L; Boisvert, D; Bradwejn, J; Campbell, W; Chouinard, G | 1 |
Waddington, JL | 1 |
Hwu, HG; Nakra, BR | 1 |
Furukawa, T; Yamada, K | 1 |
Amico, E; Goff, DC; Hubbard, JW; Midha, KK; Sarid-Segal, O | 1 |
Brauzer, B; Casey, DE; Davis, JM; Gierl, B; Hassan, M; Kane, JM; Marder, SR; Schooler, N | 1 |
Gamble, G; Greenstein, RA; McLellan, AT; Stone, AM | 1 |
Dhopesh, V; Gamble, G; Maany, I; Macfadden, A | 1 |
Conley, RR; Kelly, DL; Love, RC; Moore, DB; Sherr, JD | 1 |
Arana, GW; Gerding, LB; Labbate, LA; Measom, MO; Santos, AB | 1 |
Chengappa, KN; Jeste, DV; Mamo, DC; Reddy, RR; Sweet, RA | 1 |
Miller, DD | 1 |
Conley, RR; Kelly, DL; Love, RC; McMahon, RP | 1 |
Allahham, A; Mainwaring, DE; Marriott, J; Stewart, P | 1 |
Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M | 1 |
McEvoy, JP | 1 |
Ascher-Svanum, H; Faries, D; Marder, SR; Montgomery, W; Shi, L; Zhu, B | 1 |
Britvić, D; Ille, T; Stanković, Z; Vuković, O | 1 |
Dziuba, J; Keshavan, M; Lachover, L; Manji, S; Pizzuti, A; Rajarethinam, R | 1 |
Citrome, L; Jaffe, A; Levine, J | 1 |
Bellaaj, R; Bouguerra, C; Gallali, S; Mehdi, F; Oumaya, A; Sejil, I | 1 |
Kirk Morton, N; Zubek, D | 1 |
Den, R; Mimura, M; Sakurai, H; Suzuki, T; Tsutsumi, C; Uchida, H; Uchida, T | 1 |
6 review(s) available for fluphenazine depot and haloperidol
Article | Year |
---|---|
Neuroleptic plasma levels.
Topics: Antipsychotic Agents; Biological Availability; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Perphenazine; Schizophrenia; Thiothixene | 1991 |
Blood levels of neuroleptics: state of the art.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chlorpromazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Humans; Mental Disorders; Phenothiazines; Research Design; Thioridazine; Thiothixene | 1985 |
Low-dose treatment strategies.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Hospitalization; Humans; Male; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1986 |
Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches.
Topics: Adult; Antipsychotic Agents; Biological Availability; Chromatography; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Kinetics; Magnetic Resonance Spectroscopy; Male; Middle Aged; Psychotic Disorders; Radioimmunoassay; Radioligand Assay | 1984 |
Dose response of prophylactic antipsychotics.
Topics: Administration, Oral; Aftercare; Antipsychotic Agents; Combined Modality Therapy; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Humans; Patient Compliance; Psychotherapy; Recurrence; Schizophrenia; Schizophrenic Psychology | 1993 |
Risks versus benefits of different types of long-acting injectable antipsychotics.
Topics: Administration, Oral; Antipsychotic Agents; Fluphenazine; Haloperidol; Health Care Costs; Humans; Injections, Intramuscular; Microspheres; Quality of Life; Risk Assessment; Risperidone; Schizophrenia; Schizophrenic Psychology; Secondary Prevention; Treatment Refusal | 2006 |
11 trial(s) available for fluphenazine depot and haloperidol
Article | Year |
---|---|
[Clinical and economic approach to evaluation of the effectiveness of moditen-depot and haloperidol decanoate in the maintenance therapy of attack-like schizophrenia].
Topics: Antipsychotic Agents; Cost-Benefit Analysis; Fluphenazine; Haloperidol; Humans; Remission Induction; Schizophrenia | 1990 |
Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.
Topics: Adult; Aged; Biological Availability; Double-Blind Method; Female; Fluphenazine; Half-Life; Haloperidol; Humans; Male; Middle Aged; Prolactin; Radioimmunoassay; Schizophrenia | 1990 |
A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1989 |
Low-dose treatment strategies.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Haloperidol; Hospitalization; Humans; Male; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1986 |
Haloperidol decanoate v. fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Random Allocation; Schizophrenia | 1987 |
A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia | 1986 |
Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
Topics: Adult; Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prolactin; Schizophrenia | 1986 |
Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.
Topics: Adult; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Schizophrenia | 1985 |
A double-blind, controlled clinical trial of haloperidol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Fluphenazine; Haloperidol; Humans; Male; Schizophrenia | 1984 |
A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia.
Topics: Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluphenazine; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1995 |
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2004 |
41 other study(ies) available for fluphenazine depot and haloperidol
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Lowest effective dose of depot neuroleptics.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 1992 |
Psychotic symptoms preceding ocular deviation in a patient with tardive oculogyric crises.
Topics: Adult; Antipsychotic Agents; Benztropine; Chlorpromazine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Infusions, Intravenous; Male; Neurologic Examination; Ocular Motility Disorders; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology | 1992 |
Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.
Topics: Adult; Chronic Disease; Drug Therapy, Combination; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Metabolic Clearance Rate; Psychotic Disorders | 1990 |
Fluphenazine decanoate: a clinical problem?
Topics: Antipsychotic Agents; Chlorpromazine; Dose-Response Relationship, Drug; Fluphenazine; Haloperidol; Humans; Schizophrenia; Schizophrenic Psychology | 1989 |
Clinical implications of increased antipsychotic plasma concentrations upon anticonvulsant cessation.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Intellectual Disability; Neurocognitive Disorders; Schizophrenia; Substance Withdrawal Syndrome | 1989 |
[Possibilities for research on the proton-acceptor action of drug preparations].
Topics: Carbonyl Cyanide m-Chlorophenyl Hydrazone; Dose-Response Relationship, Drug; Electric Conductivity; Fluphenazine; Haloperidol; In Vitro Techniques; Lipid Bilayers; Methods; Methotrimeprazine; Phospholipids; Protons; Solutions | 1987 |
Effects of neuroleptic drugs on brain beta-endorphin immunoreactivity.
Topics: Animals; Antipsychotic Agents; beta-Endorphin; Brain Chemistry; Chlorpromazine; Corpus Striatum; Dopamine; Endorphins; Fluphenazine; Haloperidol; Limbic System; Male; Radioimmunoassay; Rats; Rats, Inbred Strains | 1985 |
Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review.
Topics: Animals; Antipsychotic Agents; Benztropine; Cebus; Death, Sudden; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Macaca; Male; Motor Activity; Stereotyped Behavior; Substance Withdrawal Syndrome | 1985 |
Heatstroke in a chronic schizophrenic patient treated with high-potency neuroleptics.
Topics: Antipsychotic Agents; Benztropine; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluphenazine; Haloperidol; Heat Exhaustion; Humans; Male; Middle Aged; Schizophrenia | 1985 |
Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens.
Topics: Animals; Antipsychotic Agents; Enkephalin, Methionine; Flupenthixol; Fluphenazine; Haloperidol; Male; Nucleus Accumbens; Perphenazine; Phenothiazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Septal Nuclei; Sulpiride; Time Factors | 1986 |
Depot neuroleptics for acutely psychotic patients.
Topics: Acute Disease; Antipsychotic Agents; Fluphenazine; Haloperidol; Humans; Psychotic Disorders | 1987 |
Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenics.
Topics: Adolescent; Adult; Antipsychotic Agents; Chlorpromazine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Male; Platelet Aggregation; Procyclidine; Schizophrenia; Sulpiride; Trifluoperazine | 1987 |
Effects of neuroleptic treatments on peripheral opioid secretion.
Topics: Adult; Antipsychotic Agents; beta-Endorphin; beta-Lipotropin; Chlorpromazine; Chronic Disease; Dibenzothiazepines; Drug Therapy, Combination; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Receptors, Opioid; Schizophrenia | 1987 |
Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.
Topics: Animals; Female; Fluphenazine; Haloperidol; Mouth; Movement; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1988 |
Neuroleptic drug-induced coagulopathy: mechanism of reaction and duration of effect.
Topics: Adult; Blood Coagulation Disorders; Chlorpromazine; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Partial Thromboplastin Time; Splenomegaly; Time Factors | 1986 |
Long-acting therapy of schizophrenia.
Topics: Adolescent; Adult; Antiparkinson Agents; Benzodiazepines; Biofeedback, Psychology; Bromocriptine; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Pimozide; Schizophrenia; Trimeprazine | 1985 |
Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
Topics: Adult; Aged; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Growth Hormone; Haloperidol; Humans; Male; Middle Aged; Pituitary Function Tests; Prolactin; Schizophrenia; Stimulation, Chemical; Thyrotropin-Releasing Hormone | 1981 |
Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1983 |
Effects of neuroleptic drugs on brain somatostatin-like-immunoreactivity.
Topics: Animals; Antipsychotic Agents; Apomorphine; Brain Chemistry; Chlorpromazine; Fluphenazine; Haloperidol; Male; Peptides; Pimozide; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Information processing and neuroleptic response in acute and stabilized schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Cognition; Fluphenazine; Haloperidol; Humans; Male; Pattern Recognition, Visual; Schizophrenia; Schizophrenic Psychology | 1984 |
Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Chlorocebus aethiops; Dopamine; Female; Fluphenazine; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Serotonin; Tyrosine 3-Monooxygenase | 1982 |
Tardive dyskinesia, fluphenazine decanoate, and haloperidol.
Topics: Dyskinesia, Drug-Induced; Fluphenazine; Haloperidol; Humans | 1982 |
Catatonic-like syndrome during neuroleptic therapy.
Topics: Aged; Catatonia; Female; Fluphenazine; Haloperidol; Humans | 1982 |
Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.
Topics: Aminooxyacetic Acid; Animals; Antiparkinson Agents; Catalepsy; Delayed-Action Preparations; Drug Synergism; Enkephalins; Fluphenazine; Haloperidol; Humans; Male; Mice; Mice, Inbred Strains; Receptors, Dopamine | 1982 |
Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication.
Topics: Adult; Ambulatory Care; Chronic Disease; Cocaine; Combined Modality Therapy; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Middle Aged; Schizophrenia; Schizophrenic Psychology; Substance Abuse Detection; Substance-Related Disorders; Veterans | 1993 |
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Schizophrenia | 1997 |
Rehospitalization rates for depot antipsychotics and pharmacoeconomic implications: comparison with risperidone.
Topics: Antipsychotic Agents; Baltimore; Chronic Disease; Delayed-Action Preparations; Disease-Free Survival; Female; Fluphenazine; Haloperidol; Humans; Length of Stay; Male; Patient Readmission; Risperidone; Schizophrenia; Time Factors | 1998 |
Alcohol dependence and hospitalization in schizophrenia.
Topics: Adult; Alcoholism; Antipsychotic Agents; Cocaine-Related Disorders; Comorbidity; Female; Fluphenazine; Haloperidol; Humans; Length of Stay; Male; Marijuana Abuse; Middle Aged; Patient Readmission; Retrospective Studies; Risk Factors; Schizophrenia; Treatment Refusal | 1999 |
The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Haloperidol; Humans; Male; Middle Aged; Prodrugs; Psychotic Disorders; Schizophrenia | 2002 |
Clozapine and tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Fluphenazine; Haloperidol; Humans; Longitudinal Studies; Schizophrenia, Paranoid | 2003 |
Rehospitalization risk with second-generation and depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Data Collection; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Patient Readmission; Pirenzepine; Risperidone; Schizophrenia; Secondary Prevention; Time Factors; Treatment Outcome | 2003 |
Flow and injection characteristics of pharmaceutical parenteral formulations using a micro-capillary rheometer.
Topics: Capillary Action; Chemistry, Pharmaceutical; Flow Injection Analysis; Flupenthixol; Fluphenazine; Haloperidol; Infusions, Parenteral; Medroxyprogesterone Acetate; Rheology; Suspensions; Viscosity | 2004 |
Characteristics and use patterns of patients taking first-generation depot antipsychotics or oral antipsychotics for schizophrenia.
Topics: Administration, Oral; Adult; Alcoholism; Antipsychotic Agents; Black People; Cohort Studies; Comorbidity; Crime; Cross-Sectional Studies; Delayed-Action Preparations; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Illicit Drugs; Male; Middle Aged; Patient Readmission; Prospective Studies; Schizophrenia; Schizophrenia, Disorganized; Schizophrenic Psychology; Substance-Related Disorders; Treatment Outcome; United States; White People | 2007 |
Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
Topics: Administration, Oral; Adult; Age Factors; Ambulatory Care; Antipsychotic Agents; Clozapine; Cross-Sectional Studies; Delayed-Action Preparations; Female; Fluphenazine; Haloperidol; Health Knowledge, Attitudes, Practice; Humans; Long-Term Care; Male; Middle Aged; Patient Compliance; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Yugoslavia | 2008 |
Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Risperidone; Schizophrenia | 2009 |
Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Female; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Kaplan-Meier Estimate; Length of Stay; Male; Microspheres; Middle Aged; Patient Discharge; Proportional Hazards Models; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2010 |
[Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Movement Disorders; Neurologic Examination; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Surveys and Questionnaires; Tunisia | 2013 |
Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia.
Topics: Antipsychotic Agents; Benzodiazepines; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Injections; Isoxazoles; Medication Adherence; Olanzapine; Paliperidone Palmitate; Palmitates; Risperidone; Schizophrenia | 2013 |
Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Drug Combinations; Female; Fluphenazine; Haloperidol; Humans; International Classification of Diseases; Longitudinal Studies; Maintenance Chemotherapy; Male; Medical Records; Medication Adherence; Middle Aged; Retrospective Studies; Schizophrenia; Secondary Prevention; Treatment Outcome | 2013 |